These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3978647)

  • 1. Phase I study and pharmacokinetics of weekly high-dose 13-cis-retinoic acid.
    Clamon G; Chabot GG; Valeriote F; Davilla E; Vogel C; Gorowski E; Birch R
    Cancer Res; 1985 Apr; 45(4):1874-8. PubMed ID: 3978647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
    Supko JG; Eder JP; Ryan DP; Seiden MV; Lynch TJ; Amrein PC; Kufe DW; Clark JW
    Clin Cancer Res; 2003 Nov; 9(14):5178-86. PubMed ID: 14613997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer.
    Goodman GE; Einspahr JG; Alberts DS; Davis TP; Leigh SA; Chen HS; Meyskens FL
    Cancer Res; 1982 May; 42(5):2087-91. PubMed ID: 7039822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer.
    Cura JE; Blanzaco DP; Brisson C; Cura MA; Cabrol R; Larrateguy L; Mendez C; Sechi JC; Silveira JS; Theiller E; de Roodt AR; Vidal JC
    Clin Cancer Res; 2002 Apr; 8(4):1033-41. PubMed ID: 11948110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
    Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
    Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetic study of 13-cis-retinoic acid in man.
    Besner JG; Leclaire R; Band P; Meloche S; Deschamps M; Mailhot S; Moisan R; Diorio G
    Cancer Treat Rep; 1985 Mar; 69(3):275-7. PubMed ID: 3856478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
    Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
    Park SH; Gray WC; Hernandez I; Jacobs M; Ord RA; Sutharalingam M; Smith RG; Van Echo DA; Wu S; Conley BA
    Clin Cancer Res; 2000 Mar; 6(3):847-54. PubMed ID: 10741706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.
    Ryan CW; Vogelzang NJ; Vokes EE; Kindler HL; Undevia SD; Humerickhouse R; André AK; Wang Q; Carr RA; Ratain MJ
    Clin Cancer Res; 2004 Jul; 10(13):4406-11. PubMed ID: 15240529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
    Grem JL; Harold N; Keith B; Chen AP; Kao V; Takimoto CH; Hamilton JM; Pang J; Pace M; Jasser GB; Quinn MG; Monahan BP
    Clin Cancer Res; 2002 Jul; 8(7):2149-56. PubMed ID: 12114415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical study with pharmacokinetic analysis of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193) administered as a five-day infusion.
    Trump DL; Tutsch KD; Koeller JM; Tormey DC
    Cancer Res; 1985 Jun; 45(6):2853-8. PubMed ID: 3986812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation.
    Beer TM; Munar M; Henner WD
    Cancer; 2001 Jun; 91(12):2431-9. PubMed ID: 11413535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies.
    Advani R; Fisher GA; Lum BL; Jambalos C; Cho CD; Cohen M; Gollerkeri A; Sikic BI
    Clin Cancer Res; 2003 Nov; 9(14):5187-94. PubMed ID: 14613998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.
    Mita M; Mita A; Sarantopoulos J; Takimoto CH; Rowinsky EK; Romero O; Angiuli P; Allievi C; Eisenfeld A; Verschraegen CF
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):287-95. PubMed ID: 19034451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
    Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
    Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer.
    Recchia F; De Filippis S; Rosselli M; Saggio G; Cesta A; Fumagalli L; Rea S
    Clin Cancer Res; 2001 May; 7(5):1251-7. PubMed ID: 11350891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
    Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
    Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of pentamethylmelamine: a clinical and pharmacologic study.
    Ihde DC; Dutcher JS; Young RC; Cordes RS; Barlock AL; Hubbard SM; Jones RB; Boyd MR
    Cancer Treat Rep; 1981; 65(9-10):755-62. PubMed ID: 6791819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.